Priorities and Positions
Under the guidance of our members we identify and act on issues that will impact the profession of endocrinology and patients with endocrine conditions. See how you can become involved and take action.
Our policy priorities include:
- Increased funding for the National Institutes of Health (NIH)
- Ensuring health reform efforts have a positive impact on beneficiaries
- Improved regulation of endocrine disrupting chemicals (EDCs) in the United States and internationally
- Influencing new physician payment models
- Reduction in the prevalence of diabetes and obesity
- Protecting access to care for women and transgender patients
- Improved research policy
Position Statements
At the Endocrine Society, we are concerned about a number of critical policy issues. Our goals are to ensure that the full body of research available is available to policy makers and to affect positive change by advocating for increased research and updated regulatory processes.
- Biomedical Research Funding | July 2018
A half century of sustained investment by the United States Federal Government in biomedical research has dramatically advanced the health and improved the lives of the American people… - Endocrine-Disrupting Chemicals | May 2018
Endocrine-disrupting chemicals (EDCs) are defined as: “an exogenous chemical, or mixture of chemicals, that can interfere with any aspect of hormone action”… - Endocrine-Disrupting Chemicals in the European Union | May 2018
The European Union (EU) has introduced specific legislative obligations aimed at phasing out endocrine disruptors… - Stem Cell Research | January 2018
Regenerative therapy using stem cells holds great promise for the treatment of millions of Americans... - Compounded Bioidentical Hormone Therapy | September 2017
Compounded “Bioidentical” Hormone Therapy (cBHT), particularly estrogen and progesterone, have been promoted by… - Ensuring Affordable Access to Hormonal Contraception | September 2017
The majority of women of reproductive age in the United States currently use at least one contraceptive method… - Transgender Health | September 2017
Over the last few decades, there has been a rapid expansion in the understanding of gender identity… - Central Institutional Review Boards | April 2016
Clinical research involving human participants is critical to develop treatments for a broad… - Affordable Care Act Implementation: Challenges and Opportunities to Impact Patients With Diabetes | January 2016
In the United States, slightly more than half of all adults with diabetes receive… - Pediatric Obesity | November 2011
Pediatric obesity in the United States is an epidemic. Although obesity rates vary… - Bioequivalence of Sodium Levothyroxine | June 2008
The Endocrine Society is concerned that patients are frequently being placed at risk by the… - Access to Affordable and Adequate Diabetes Supplies | October 2007
Diabetes is a life-threatening disease affecting more than 20 million Americans… - Clinical Trial Registries | June 2006
In response to the growing public concern about the timely and complete reporting…
Additional Society Policy Documents
- The Real Costs of Diabetes: What Policy Makers Need to Know Congressional Briefing Flier |October 1, 2018
- Richardson vs. Chicago Transit Authority | August 28, 2019
The Endocrine Society signed onto an amicus brief recognizing obesity as a disease and supporting its inclusion under the Americans with Disabilities Act’s definition of impairment. - Proposed Updates to Year 3 of the Quality Payment Program | July 2018
- CY 2019 Physician Fee Schedule Proposed Rule Summary | July 2018
- Fiscal Year (FY) 2017 Appropriations Summary | May 2017
- Priorities for Health System Reform | January 2017
The Endocrine Society outlines its core principles for policymakers to consider if healthcare reform is enacted. - Hypoglycemia Quality Collaborative Strategic Blueprint | October 2016
Report and Recommendations: A Resource to Increase Awareness of Hypoglycemia and Promote Activities to Reduce Its Incidence